PHASE 3 EFFICACY AND SAFETY DATA FROM RANDOMIZED, MULTICENTER STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (ARIKACE) COMPARED WITH TOBI (R) IN CYSTIC FIBROSIS PATIENTS WITH CHRONIC INFECTION DUE TO PSEUDOMONAS AERUGINOSA

Bilton, D; Pressler, T; Isabelle, F; Sands, D; Minic, P; Cipolli, M; LaRosa, M; Galeva, I; Sole, A; Staab, D; Dupont, Lieven; Goss, CH; Hamblett, NM; Quittner, AL; Ramsey, B; Gupta, R; Konstan, MW

Pediatric Pulmonology

PHASE 3 EFFICACY AND SAFETY DATA FROM RANDOMIZED, MULTICENTER STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (ARIKACE) COMPARED WITH TOBI (R) IN CYSTIC FIBROSIS PATIENTS WITH CHRONIC INFECTION DUE TO PSEUDOMONAS AERUGINOSA

Author:

Bilton, D

Pressler, T ; Isabelle, F ; Sands, D ; Minic, P ; Cipolli, M ; LaRosa, M ; Galeva, I ; Sole, A ; Staab, D ; Dupont, Lieven ; Goss, CH ; Hamblett, NM ; Quittner, AL ; Ramsey, B ; Gupta, R ; Konstan, MW

Keywords:

Science & Technology, Life Sciences & Biomedicine, Pediatrics, Respiratory System, 1114 Paediatrics and Reproductive Medicine, 3201 Cardiovascular medicine and haematology, 3213 Paediatrics

Pediatric Pulmonology PHASE 3 EFFICACY AND SAFETY DATA FROM RANDOMIZED, MULTICENTER STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (ARIKACE) COMPARED WITH TOBI (R) IN CYSTIC FIBROSIS PATIENTS WITH CHRONIC INFECTION DUE TO PSEUDOMONAS AERUGINOSA

Author:

Keywords:

Pediatric Pulmonology

PHASE 3 EFFICACY AND SAFETY DATA FROM RANDOMIZED, MULTICENTER STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (ARIKACE) COMPARED WITH TOBI (R) IN CYSTIC FIBROSIS PATIENTS WITH CHRONIC INFECTION DUE TO PSEUDOMONAS AERUGINOSA